U.S. drug spending has increased dramatically in the last 20 years. Americans pay the highest drug prices in the world, which leads to higher direct spending for patients and payers—both in the private and government sectors. Meanwhile, health plans are forced to raise premiums or make benefits less generous as prices continue to skyrocket. In this paper, Abt authors highlight the causes of these increases, and identify possible strategies that the Center for Medicare & Medicaid Services (CMS) could pursue to combat the rise in prices. Additionally, previous work for CMS and others is cited to help illustrate how research and evaluations can help identify and validate strategies.
Read More
Health Policy & Systems in North America
Abt Global Wins Seat on CMS RMADA 3 Contract Vehicle
Abt Global has been awarded a seat on the Centers for Medicare & Medicaid Services’ (CMS) Research, Measurement, Assessment, Design, and Analysis 3 contract vehicle, known as RMADA 3.
What Makes Rural Health Hubs Work? An Evaluation Framework for States
Abt’s framework for evaluating rural health hubs and measuring access, coordination, population health, and system resilience.
Connecting Care for Children and Families: Testing New Approaches to Improve Outcomes and Manage Costs
Abt is evaluating if new approaches to CMS’s Integrated Care for Kids (InCK) Model can improve outcomes for Medicaid-enrolled children while controlling costs.
NRHA's 49th Annual Rural Health Conference
Abt’s 60 years of federal health work help partners address today’s toughest rural health challenges – let's connect in California.